Why it matters

The Senate Judiciary Committee voted March 26 to advance three bipartisan bills — including landmark legislation scheduling the deadly drug xylazine. The meeting, however, was overshadowed by a raw partisan clash over Robert Mueller's death and the FBI's direction. The tension exposed a committee simultaneously capable of bipartisan legislating and deeply divided over the Trump administration's conduct.

The Big Picture

The 119th Congress hearing convened to mark up S. 545, the Combating Illicit Xylazine Act, H.R. 2159, the Count the Crimes to Cut Act, and S. 2934, the Protecting Americans from Russian Litigation Act, alongside two U.S. Marshal nominations.

The xylazine bill had been held over from a March 19 markup after Democrats raised transparency concerns. During the intervening week, Sen. Chuck Grassley (R-IA) worked with Sens. Whitehouse, Coons, and Booker to revise the manager's amendment — requiring both HHS's scientific evaluation and DEA's law enforcement evaluation to be released together in a combined public report to Congress. The DEA has seized xylazine-fentanyl mixtures in 48 states; the White House's Office of National Drug Control Policy had previously declared fentanyl mixed with xylazine an emerging threat. The Trump administration has been broadly supportive of the bill's scheduling approach.

The Count the Crimes to Cut Act, which already passed the House by voice vote, aligns with Trump's Executive Order 14294 on fighting overcriminalization. The Russian litigation bill — protecting American companies from retaliatory Russian court judgments — advanced with bipartisan backing from Sens. Cornyn and Padilla. The committee advanced all three bills and both nominations.

What They're Saying

The Senate Judiciary Committee hearing produced some of the sharpest exchanges of the 119th Congress.

Sen. Dick Durbin (D-IL), the Ranking Member, opened with a direct attack on the administration, citing Trump's reported response to former FBI Director Robert Mueller's recent death:

"When Mr. Mueller died last week, President Trump responded with the following words: 'Good. I'm glad he's dead.' We cannot pretend that this cruel and un-American behavior is normal."

Durbin then turned to FBI Director Kash Patel:

"Patel has one quality that authoritarians prize above all: a willingness to do whatever he is asked to do, regardless of what the law requires."

Grassley fired back, framing the committee's ongoing Jack Smith investigation as methodical, not stalled:

"This committee is not going to give in to the Democrats' ill-advised strategy to bring Jack Smith in before our investigative record is entirely ready."

The atmosphere was tense but controlled. Grassley moved through the legislative agenda briskly after his opening, and Durbin — notably — closed his remarks by requesting to be added as a co-sponsor of the xylazine bill. Grassley responded simply: "You will be added as a co-sponsor."

The Legislative Substance

Xylazine: Science vs. Speed

The most substantive exchange came from Sen. Cory Booker (D-NJ), who praised the revised amendment but pressed on process:

"We are doing this all backwards. We're not incorporating the scientific evidence into our decisions. And that to me is disappointing."

Booker argued that HHS had actually recommended Schedule 5 — the least restrictive classification — while the bill places xylazine at Schedule 3. He noted the DEA bypassed the standard statutory process and came directly to Congress. His critique did not stop the bill; it passed out of committee. But it signaled that the legislation may face scrutiny on the Senate floor over whether Congress moved too fast ahead of the science.

The bill drew letters from more than 200 family advocacy groups and has backing from the DEA, the American Veterinary Medical Association, and the Peace Officers Research Association of California.

Criminal Code Transparency

Sen. Mike Lee (R-UT), lead Senate sponsor of the Count the Crimes to Cut Act alongside Sen. Chris Coons (D-DE), put the core problem plainly:

"The people at the Congressional Research Service — whose job it is to research these things — got back to us and said that the answer is unknown and unknowable, but the figure stands at at least 300,000 [federal crimes] when you take into account everything in the code and also in the Code of Federal Regulations."

The bill's left-right coalition — Lee and Cruz alongside Booker and Welch — is rare in the current Congress.

Russian Litigation

Sen. Ashley Moody (R-FL) framed the Russian litigation bill in stark terms:

"Americans should not be forced to choose between complying with the laws of the United States and facing legal consequences abroad that follow them back home."

The bill's lead sponsor, Sen. John Cornyn (R-TX), noted the Cornyn-Padilla (D-CA) partnership as evidence that Texas and California can find common ground — a pointed contrast to the rest of the hearing's atmosphere.

Political Stakes

For Grassley: The Iowa Republican is managing two simultaneous agendas — bipartisan legislating and a high-stakes oversight investigation into the prior administration. His ability to advance the xylazine bill with Democratic co-sponsors while simultaneously prosecuting the Jack Smith probe reinforces his brand as a legislator who can do both. His prior nomination of Brian Gootkin as U.S. Marshal for Montana had already been returned to the President once under Senate Rule XXXI — the committee's action this week clears that backlog.

For Democrats: Durbin's opening was the most politically charged statement of the session, but his caucus members — not Durbin himself — negotiated the xylazine amendment. That dynamic suggests Democrats are finding ways to claim legislative wins in the minority while maintaining sharp rhetorical opposition on oversight.

For the public: The xylazine bill, if enacted, would give law enforcement clearer tools against a drug that is already present in 48 states and cannot be reversed by naloxone. The criminal code transparency bill could, for the first time, produce a public inventory of how many federal crimes actually exist.

Yes, But

The hearing's bipartisan legislative output masks a deeper dysfunction. Sen. Adam Schiff (D-CA) warned the committee could be hamstrung in its planned Jack Smith testimony without the sealed second volume of Smith's report — covering the Mar-a-Lago classified documents investigation. Schiff disclosed that some of those documents "implicated the president's business interests" and urged the committee to intervene with the Florida court holding the report. Grassley agreed to have staff follow up — a rare moment of procedural cooperation on an otherwise combustible topic.

What's Next

  • S. 545 was ordered reported with an amendment in the nature of a substitute. Senate floor scheduling and a potential House companion action are the next variables.
  • H.R. 2159, having already passed the House by voice vote, could go directly to the President upon Senate floor passage.
  • S. 2934 moves to the full Senate, where its business-community backing from the U.S. Chamber of Commerce may accelerate floor consideration.
  • The Jack Smith hearing — the "Arctic Frost" proceeding — remains on the committee's calendar, with Grassley signaling the investigative record is not yet complete.

The Bottom Line

The Senate Judiciary Committee advanced three substantive bills in a single session, but the hearing's lasting image may be Durbin quoting Trump's reported reaction to Robert Mueller's death — a reminder that even routine legislative business now unfolds against an extraordinary political backdrop.

Access the Legis1 platform for comprehensive political news, data, and insights.

Spot something wrong? Report an issue with this article